Back to Agenda
Artificial Intelligence in Drug Discovery and Development: Emerging Technologies and Applications
Session Chair(s)
Scott Spangler, MA
Distinguished Engineer, Chief Data Scientist for Life Sciences , IBM Watson, United States
Learning Objective : Describe translatable experiences and practices concerning impactful applications of artificial intelligence.
Speaker(s)
Erica Majumder, PhD
Postdoctoral Research Fellow, Center for Mass Spectrometry and Metabolomics, Scripps Research, United States
Panelist: Activity Metabolomics and ArtificiaI Predictions
Yudong Cao, PhD, MS
Co-founder and CTO, Zapata Computing, United States
Challenges and Opportunities in Near-Term Quantum Computation
Craig Lipset, MPH
Co-Chair, Digital Trials and Research Alliance, United States
Panelist
Have an account?